Navigation Links
GeoVax Labs Announces Availability of 2010 Annual Report and President's Letter to Stockholders
Date:5/4/2011

ATLANTA, May 4, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, today released its 2010 Annual Report and President's Letter to the Company's stockholders.  The Annual Report (10-K) provides information on the state of the Company's finances at the conclusion of 2010.  In his Letter, GeoVax's President Robert T. McNally, Ph.D., provides a concise overview of the Company's Therapeutic Vaccine Program, Preventative Vaccine Program, and Financing and Corporate Development.

The 2010 Annual Report and President's Letter are available on the Company's website at www.geovax.com.

About GeoVax

GeoVax Labs, Inc. is a biotechnology company developing human vaccines for diseases caused by HIV (Human Immunodeficiency Virus – that leads to AIDS). Our HIV/AIDS vaccine technology is exclusively licensed from Emory University in Atlanta, GA, and is the subject of more than 20 issued or filed patent applications.  GeoVax's vaccines are unique in expressing virus-like particles that display the trimeric membrane bound form of the HIV-1 envelope glycoprotein.  Our preventative vaccines are designed for use in uninfected people to prevent acquisition of HIV-1 and are moving forward in human clinical trials conducted by the HIV Vaccine Trials Network (HVTN). The HVTN, funded through a cooperative agreement with the NIH, is the largest worldwide clinical trials program dedicated to the development and testing of AIDS vaccines.  GeoVax's vaccines also may be effective as a therapeutic treatment (for people already infected with the HIV-1 virus); a Phase 1/2 human trial for the therapeutic application of our vaccine is ongoing.  Preclinical work enabling evaluation of the GeoVax DNA and MVA vaccines was funded and supported by the National Institute of Allergy and Infectious Disease (NIAID), whic
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. GeoVax Labs, Inc. Announces First Quarter Financial Results
2. GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results
3. GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony
4. GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting
5. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
6. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
7. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
8. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
9. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
10. GeoVax Labs Requests pre-IND Meeting With FDA
11. GeoVax to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Inflamax scientists worked closely with internationally ... the study, which will provide critical insight into ... in the study of allergy treatments, the Environmental ... models. Although both the models are well recognized ... direct comparison between the allergic responses evoked by ...
(Date:5/21/2013)... 21, 2013 PathoGenetix, Inc., a commercial-stage ... typing, announced today that it has successfully identified and ... strains obtained from the Centers for Disease Control and ... technology. The findings are detailed in a poster ... Society for Microbiology in Denver on Monday. , The ...
(Date:5/20/2013)... (PRWEB) May 21, 2013 Grace ... specializing in “game-changing” life science and health related private ... Dergham to its International Project Team. Dergham's expertise in ... greater multi-cultural depth to Grace Century as it continues ... globe. , Ms. Dergham holds both an under graduate ...
(Date:5/20/2013)... Calif. , May 20, 2013  (PSHR) ... providing naturally based products across a broad range ... company has retained investor relations firm, BlueWater Advisory ... the return to trading process, and to direct ... trading initiation. Matthew Mills ...
Breaking Biology Technology:Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2
... Aug. 23 Monogram,Biosciences, Inc. (Nasdaq: MGRM ) ... scheduled to present a corporate overview at the Thomas,Weisel ... 3:15 p.m. (Eastern Time) at the Four Seasons Hotel ... or the subsequent archived,recording, log on to http://www.monogrambio.com ...
... Conn., Aug. 22 Biodel, Inc. (Nasdaq:,BIOD) ... M.D., to its,Scientific Advisory Board (SAB). ... President of Research,and Development at Kos Pharmaceuticals, ... until Kos was acquired by Abbott Laboratories. ...
... ZymoGenetics, Inc. (Nasdaq:,ZGEN) announced that the company ... update on the regulatory review of recombinant thrombin,(rThrombin). ... on August 22 at 5:00,p.m. Eastern Time by ... the call approximately 10 minutes prior to,the scheduled ...
Cached Biology Technology:Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007 2Ralf Rosskamp, M.D. Joins Biodel's Scientific Advisory Board 2Ralf Rosskamp, M.D. Joins Biodel's Scientific Advisory Board 3ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin 2
(Date:5/21/2013)... in shape is an uphill battle? Try staying fit ... weightlessness withers muscle and bone. , That,s the challenge ... with a new three-year, $1.2 million grant from NASA. ... during multiyear exploratory missions. , "You could give astronauts ... can,t get them to stick to it, it isn,t ...
(Date:5/21/2013)... Where? Copenhagen, Denmark: Bella Center Congress Centre ... , Why? An annual meeting focusing ... manufacturing and installation, drawing on leading experiences from all ... from a record of more than 900 abstracts received ... and oral presentations, more than 460 visual presentation, 55 ...
(Date:5/21/2013)... way genes function without changing the underlying DNA ... of pregnant women during any trimester, potentially providing ... weeks after giving birth, and an opportunity to ... of the small study involving 52 pregnant women ... Psychiatry . , "Postpartum depression can be harmful ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... Fish become feisty but fearful when facing themselves in ... like something they don,t understand," said Julie Desjardins, a post-doctoral ... be published in Biology Letters describing the study. ... is just so far outside their realm of experience that ...
... of life" has been constructed by researchers at ... for the gamma-proteobacteria, a large group of medically ... Salmonella typhimurium, and other disease-causing organisms.* By building ... identify similarities and differences between the make-up of ...
... A research collaboration lead by a professor from ... work to develop methods to protect agriculturally important crops ... with the support of a $1.45 million award from ... sponsored by the National Science Foundation (NSF) and the ...
Cached Biology News:Fish facing reflections become feisty but fearful 2Fish facing reflections become feisty but fearful 3New 'Tree of Life' established for one of the largest groups of bacteria 2New 'Tree of Life' established for one of the largest groups of bacteria 3Plant protection research targets cacao in developing countries 2
... For use as a carrier ... precipitation. Physical form: Solution in ... 7.4, 1 mM EDTA Preparation ... Concentration: 10 ...
... Genome ChIP-on-chip Microarray is specifically designed ... cerevisiae) DNA binding proteins by pairing ... microarrays. This set delivers robust hybridization ... true binding events and fewer false ...
... White solid.. PACKAGED UNDER INERT GAS. Cyclizes as ... "driven" to completion. A protective agent for SH ... many other preparations. Blocks the lethal and hypnotic ... Contaminants: Heavy metals: ≤1 ppm. ...
... to help promote genomics-based research with S. aureus, ... that contains PCR primers to amplify all open ... addition, primer pairs are included to amplify ORFs ... N315 strains of S. aureus. The ORFmer set ...
Biology Products: